358 related articles for article (PubMed ID: 23453973)
1. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
[TBL] [Abstract][Full Text] [Related]
2. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
[TBL] [Abstract][Full Text] [Related]
3. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.
Gil C; Chaib-Oukadour I; Aguilera J
Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells.
MacAulay K; Blair AS; Hajduch E; Terashima T; Baba O; Sutherland C; Hundal HS
J Biol Chem; 2005 Mar; 280(10):9509-18. PubMed ID: 15632169
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.
Wang X; Janmaat M; Beugnet A; Paulin FE; Proud CG
Biochem J; 2002 Oct; 367(Pt 2):475-81. PubMed ID: 12133000
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons.
Hetman M; Hsuan SL; Habas A; Higgins MJ; Xia Z
J Biol Chem; 2002 Dec; 277(51):49577-84. PubMed ID: 12393899
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3B in bovine oocytes and granulosa cells: possible involvement in meiosis during in vitro maturation.
Uzbekova S; Salhab M; Perreau C; Mermillod P; Dupont J
Reproduction; 2009 Aug; 138(2):235-46. PubMed ID: 19470708
[TBL] [Abstract][Full Text] [Related]
10. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
11. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart.
Mora A; Sakamoto K; McManus EJ; Alessi DR
FEBS Lett; 2005 Jul; 579(17):3632-8. PubMed ID: 15961082
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
Lecat S; Belemnaba L; Galzi JL; Bucher B
Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
[TBL] [Abstract][Full Text] [Related]
13. RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin.
Standaert ML; Bandyopadhyay G; Antwi EK; Farese RV
Endocrinology; 1999 May; 140(5):2145-51. PubMed ID: 10218965
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
Cale JM; Bird IM
Biochem J; 2006 Sep; 398(2):279-88. PubMed ID: 16716148
[TBL] [Abstract][Full Text] [Related]
15. Expression and glycogenic effect of glycogen-targeting protein phosphatase 1 regulatory subunit GL in cultured human muscle.
Montori-Grau M; Guitart M; Lerin C; Andreu AL; Newgard CB; García-Martínez C; Gómez-Foix AM
Biochem J; 2007 Jul; 405(1):107-13. PubMed ID: 17555403
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
[TBL] [Abstract][Full Text] [Related]
17. Effect of inhibitors of mitogen-activated protein kinase kinase on alpha(1B)-adrenoceptor phosphorylation.
Alcántara-Hernández R; Adolfo García-Sáinz J
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):13-23. PubMed ID: 19302552
[TBL] [Abstract][Full Text] [Related]
18. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
19. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
